Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-03-09 Cohen Chad M Chief Financial Officer Sale −2,890 $40.79 $118K 21,064
2021-03-09 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −10,000 55,000
2021-03-09 GOEL DAVID E. Director Sale −215,698 $40.42 $8.7M 12,399,392
2021-03-09 GOEL DAVID E. Director Sale −34,302 $41.16 $1.4M 12,365,090
2021-03-08 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2021-03-08 HERSHBERG ROBERT Director Sale −2,000 $44.56 $89K 0
2021-03-08 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 53,000
2021-03-08 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 3,504
2021-03-08 HERSHBERG ROBERT Director Sale −2,000 $44.56 $89K 1,504
2021-03-08 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 53,000
2021-03-08 GOEL DAVID E. Director Sale −234,295 $38.22 $9.0M 12,880,795
2021-03-08 GOEL DAVID E. Director Sale −75,000 $39.22 $2.9M 12,805,795
2021-03-08 GOEL DAVID E. Director Sale −33,600 $39.97 $1.3M 12,772,195
2021-03-08 GOEL DAVID E. Director Sale −71,194 $41.21 $2.9M 12,701,001
2021-03-08 GOEL DAVID E. Director Sale −85,911 $41.62 $3.6M 12,615,090
2021-03-04 ROBINS HARLAN S Chief Scientific Officer Grant or award +68,681 69,360
2021-03-04 ROBINS HARLAN S Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +171,703 171,703
2021-03-04 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Grant or award +9,158 9,158
2021-03-04 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Grant or award · Stock Option (Right to Buy) +22,894 22,894
2021-03-04 BALDO LANCE Chief Medical Officer Grant or award +22,894 22,894

Page 54 of 120 · 2,386 trades